Fobi AI Inc
XTSX:FOBI
Fobi AI Inc
XTSX:FOBI
Price:
0.04
CAD
Market Closed
Market Cap:
CA$9.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Fobi AI Inc
XTSX:FOBI
|
CA |
|
Jinan Acetate Chemical Co Ltd
TWSE:4763
|
CN |
|
Y
|
Yamuna Syndicate Ltd
BSE:540980
|
IN |
|
Meridian Energy Ltd
NZX:MEL
|
NZ |
|
Coastal Carolina Bancshares Inc
OTC:CCNB
|
US |
|
Yamada Corp
TSE:6392
|
JP |
|
A
|
AstraZeneca PLC
NASDAQ:AZN
|
UK |
|
S
|
Sitio Royalties Corp
NYSE:STR
|
US |
|
Bitmine Immersion Technologies Inc
OTC:BMNR
|
US |
|
Seah Steel Corp
KRX:306200
|
KR |
|
U
|
UMS Neiken Group Bhd
KLSE:UMS
|
MY |
|
T
|
Twentyfirst Century Management Services Ltd
NSE:21STCENMGM
|
IN |
|
M
|
MS International PLC
LSE:MSI
|
UK |
|
O
|
Ossur hf
CSE:OSSR
|
IS |
Income Statement
Earnings Waterfall
Fobi AI Inc
Fobi AI Inc
Income Statement
Fobi AI Inc
Fobi AI Inc
Currency: CAD
| Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Sep-2024 | Dec-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
1
N/A
|
2
+125%
|
2
+18%
|
2
+4%
|
2
-2%
|
2
-21%
|
3
+60%
|
2
-19%
|
5
+123%
|
6
+22%
|
5
-10%
|
3
-45%
|
2
-27%
|
2
-3%
|
|
| Gross Profit | |||||||||||||||
| Cost of Revenue |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
1
N/A
|
1
+105%
|
0
N/A
|
2
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||
| Operating Expenses |
(15)
|
(17)
|
(21)
|
(21)
|
(19)
|
(17)
|
(16)
|
(15)
|
(27)
|
(28)
|
(25)
|
(9)
|
(6)
|
(5)
|
|
| Selling, General & Administrative |
(15)
|
(16)
|
(20)
|
(19)
|
(17)
|
(15)
|
(14)
|
(13)
|
(23)
|
(23)
|
(21)
|
(8)
|
(5)
|
(4)
|
|
| Research & Development |
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
| Depreciation & Amortization |
(0)
|
(0)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(3)
|
(4)
|
(3)
|
(1)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(15)
N/A
|
(15)
-6%
|
(19)
-25%
|
(19)
+4%
|
(17)
+9%
|
(15)
+11%
|
(13)
+11%
|
(13)
+4%
|
(22)
-72%
|
(23)
-2%
|
(20)
+10%
|
(7)
+67%
|
(4)
+42%
|
(3)
+28%
|
|
| Pre-Tax Income | |||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(14)
N/A
|
(15)
-6%
|
(19)
-25%
|
(19)
0%
|
(18)
+7%
|
(16)
+10%
|
(15)
+10%
|
(13)
+12%
|
(22)
-73%
|
(22)
-1%
|
(20)
+11%
|
(7)
+67%
|
(4)
+41%
|
(3)
+27%
|
|
| Net Income | |||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(14)
|
(15)
|
(19)
|
(19)
|
(18)
|
(16)
|
(14)
|
(13)
|
(22)
|
(22)
|
(20)
|
(7)
|
(4)
|
(3)
|
|
| Net Income (Common) |
(14)
N/A
|
(15)
-6%
|
(19)
-25%
|
(19)
+0%
|
(18)
+7%
|
(16)
+10%
|
(14)
+10%
|
(13)
+11%
|
(22)
-73%
|
(22)
-1%
|
(20)
+11%
|
(7)
+67%
|
(4)
+41%
|
(3)
+27%
|
|
| EPS (Diluted) |
-0.11
N/A
|
-0.11
N/A
|
-0.13
-18%
|
-0.14
-8%
|
-0.12
+14%
|
-0.11
+8%
|
-0.1
+9%
|
-0.08
+20%
|
-0.14
-75%
|
-0.11
+21%
|
-0.09
+18%
|
-0.03
+67%
|
-0.02
+33%
|
-0.01
+50%
|
|
Switch to:
Switch to:
See Also
Discover More
